Intranasal Xylitol for the Treatment of COVID-19 in the Outpatient Setting: A Pilot Study.

Cureus · 2022 · PMC9395150 · PMID 36039203

Europe PMC DOI

hedged sentence

0.1330

closest p · 2.7× alpha

0.1330

boldest claim

The sentences

did not reach statistical significanceP=0.133not close (p > 0.1)

no patients with anosmia in the XYL group, although this difference did not reach statistical significance (X 2 =5.72; P=0.133).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.